The impact of empagliflozin dose on HbA1c & weight outcomes at 6 & 12 months: updated analysis from the ABCD empagliflozin audit programme

TSJ Crabtree1,2,3, A Gallagher4, I Gallen5, A Melvin6, N Morrish6, J Elliott7, A Bickerton8, REJ Ryder1 on behalf of ABCD empagliflozin audit contributors

 

1. Sandwell & West Birmingham Hospitals NHS Trust, UK
2. University Hospitals of Derby & Burton NHS Trust, UK
3. University of Nottingham, UK
4. University Hospitals Leicester NHS Trust, UK
5. Royal Berkshire NHS Foundation Trust, UK
6. Bedfordshire Hospitals NHS Trust, UK
7. Sheffield Teaching Hospitals NHS Trust, UK
8. Yeovil District Hospital NHS Trust, UK

Discipline: 
Diabetes
Clinical taxonomy: 
Treatments for diabetes
Type 2 diabetes mellitus
Resource taxonomy: 
Audit
Posters

ABCD Webinar Series

ABCD Webinars